A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue 3, 1998, Pages 306-313

  Talbot, Paul R ^a   Lloyd, James J ^a   Snowden, Julie S ^a   Neary, David ^a   Testa, Humberto J ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

99mTc HMPAO SPECT; Dementia; Likelihood ratio

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; DIAGNOSTIC AGENT;

ADULT; AGED; ALZHEIMER DISEASE; APHASIA; ARTICLE; BRAIN BLOOD FLOW; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CLASSIFICATION; DEMENTIA; FEMALE; MALE; MIDDLE AGED; PARKINSON DISEASE; PRIMARY PROGRESSIVE APHASIA; REPRODUCIBILITY; RISK; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

AGED; ALZHEIMER DISEASE; APHASIA, PRIMARY PROGRESSIVE; DEMENTIA; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031594560     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.64.3.306     Document Type: Article

References (35)

1. 99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 1987;50:1101-9.
2. Burns A, Philpot MP, Costa DC, et al. The investigation of Alzheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry 1989;52:248-53.
3. Montaldi D, Brooks DN, McColl JH, et al. Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1990;53: 33-8.
4. McKeith IG, Bartholomew PH, Irvine EM, et al. Single photon emission tomography in elderly patients with Alzheimer's disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements. Br J Psychiatry 1993;163:597-603.
5. Talbot PR, Snowden JS, Lloyd JJ, et al. The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disease. J Neurol 1995;242:579-86.
6. Neary D, Snowden JS, Bowen DM, et al. Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry 1986;49:163-74.
7. Snowden JS, Neary D, Mann DMA, et al. Progressive language disorder due to lobar atrophy. Ann Neurol 1992;31:174-83.
8. Miller BL, Cummings JL, Villanueva-Meyer J, et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 1991;41:1374-82.
9. Starkstein SE, Migliorelli R, Teson A, et al. Specificity of changes in cerebral blood flow in patients with frontal lobe dementia. J Neurol Neurosurg Psychiatry 1994;57:790-6.
10. Neary D, Snowden JS, Northen B, et al. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 1988;51:353-61.
11. Gustafson L. Clinical picture of frontal lobe degeneration of non-Alzheimer type. Dementia 1993;4:143-8.
12. Ell PJ. Single photon emission computed tomography (SPECT) of the brain. J Neurosci Methods 1990;34:207-17.
13. Talbot PR, Testa HJ. The value of SPECT imaging in dementia. Nucl Med Commun 1995;16:425-37.
14. Waldemar G. Functional brain imaging with SPECT in normal aging and dementia. Methodological, pathophysiological, and diagnostic aspects. Cerebrovasc Brain Metab Rev 1995;7:89-130.
15. Cummings JL, Benson DF. Subcortical dementia. Review of an emerging concept. Arch Neurol 1984;41:874-9.
16. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Working Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
17. Mann DMA. The topographical distribution of brain pathology in Alzheimer's disease. Acta Neuropathol 1991; 83:81-6.
18. Roman GC, Tatemichi TK, Erkinjuntti T. Vascular dementia: diagnostic criteria for research studies - a report of the NINDS-AIREN international workshop. Neurology 1993;43:250-60.
19. McKeith IG, Perry RH, Fairbairn AF, et al. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-22.
20. Mann DMA, Snowden JS. The topographic distribution of brain atrophy in cortical Lewy body disease: comparison with Alzheimer's disease. Acta Neuropathol 1995;89:178-83.
21. Brun A, England B, Gustafson L, et al. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-8.
22. Mann DMA, South PW. The topographic distribution of brain atrophy in frontal lobe dementia. Acta Neuropathol 1993;85:334-40.
23. Neary D, Snowden JS, Mann DMA. Familial progressive aphasia: its relationship to other forms of lobar atrophy. J Neurol Neurosurg Psychiatry 1993;56:1122-5.
24. Birkett NJ. Evaluation of diagnostic tests with multiple diagnostic categories. J Clin Epidemiol 1988;41:491-4.
25. Black WC, Armstrong P. Communicating the significance of radiologic test results: the likelihood ratio. AJR Am J Roentgenol 1986;147:1313-8.
26. Morris JA, Gardner MJ. Calculating confidence intervals for relative risks, odds ratios, and standardised ratios and rates. In: Martin JG, Altman DG, eds. Statistics with confidence - confidence intervals and statistical guidelines. London: BMJ, 1989.
27. Holman BL, Johnson KA, Gerada B, et al. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 1991;33:181-5.
28. Miekle R, Pietrzyk U, Jacobs A, et al. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. Eur J Nucl Med 1994;21:1041-3.
29. Read SL, Miller BL, Mena I, et al. SPECT in dementia: clinical and pathological correlation. J Am Geriatr Soc 1995;43:1243-7.
30. Habert MO, Spampinato U, Mas JL, et al. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia. Eur J Nucl Med 1991; 18:3-11.
31. Smith FW, Besson JA, Gemmell HG, et al. The use of technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric disorders. J Cereb Blood Flow Metab 1988;8:116-22.
32. 99mTc-HMPAO SPECT findings in Lewy body disease. J Neurol 1997:244: 349-59.
33. Talbot PR, Goulding PJ, Snowden JS, et al. Inter-relation between "classic" motor neuron disease and frontotemporal dementia: a neuropsychological and single photon emission computed tomography study. J Neurol Neurosurg Psychiatry 1995;58:541-7.
34. Caselli RJ, Jack CR. Asymmetric cortical degeneration syndromes. A proposed clinical classification. Arch Neurol 1992;49:770-80.
35. Kouris K, Jarritt PH, Costa DC, et al. Physical assessment of the GE/CGR Neurocam and comparison with a single rotating gamma-camera. Eur J Nucl Med 1992;19:236-42.